Bionor is a biopharmaceutical company with first mover potential to advance a possible functional HIV cure

Latest news

Hide mandatory notifications of trade

Doctoral thesis at Oslo University Hospital based on clinical studies carried out in collaboration with Bionor Pharma.

Scientific .2016

Oslo, 07.12.2016. Cand. Med. Kristin Brekke will defend her doctoral thesis entitled “Therapeutic vaccination in chronic HIV infection - clinical studies” on Thursday 8th December at Oslo University Hospital.

– Godt nytt for norsk helsenæring

Scientific .2016

Oslo, (06.12.2016) Nettverket som får overta produksjonsutstyret til Folkehelseinstituttet forteller om bakgrunnen for avgjørelsen og fremtiden til utstyret.

Bionor Pharma ASA announces warrant exercise

Financial .2016

(Oslo, Norway, 1 December 2016) Reference is made to the resolution by the EGM on 11 February 2016 to issue warrants to participants in the private placement and subsequent offering completed on 10 March 2016.

Doctoral thesis at Oslo University Hospital based on clinical studies carried out in collaboration with Bionor Pharma.

Scientific .2016

Oslo, 07.12.2016. Cand. Med. Kristin Brekke will defend her doctoral thesis entitled “Therapeutic vaccination in chronic HIV infection - clinical studies” on Thursday 8th December at Oslo University Hospital.

– Godt nytt for norsk helsenæring

Scientific .2016

Oslo, (06.12.2016) Nettverket som får overta produksjonsutstyret til Folkehelseinstituttet forteller om bakgrunnen for avgjørelsen og fremtiden til utstyret.

Bionor Pharma ASA announces warrant exercise

Financial .2016

(Oslo, Norway, 1 December 2016) Reference is made to the resolution by the EGM on 11 February 2016 to issue warrants to participants in the private placement and subsequent offering completed on 10 March 2016.

Go to news section

Featured content